• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Primary pulmonary hypertension in HIV patients: a systematic review.

作者信息

Pellicelli A M, Barbaro G, Palmieri F, Girardi E, D'Ambrosio C, Rianda A, Barbarini G, Frigiotti D, Borgia M C, Petrosillo N

机构信息

Second Division of Infectious Diseases, IRCCS Lazzaro Spallanzani Hospital, Rome, Italy.

出版信息

Angiology. 2001 Jan;52(1):31-41. doi: 10.1177/000331970105200105.

DOI:10.1177/000331970105200105
PMID:11205929
Abstract

The relationship between grade of pulmonary hypertension and factors associated with human immunodeficiency virus among patients with HIV infection is poorly documented. This report documents the most extensive attempt made thus far to determine whether a relationship exists between degree of pulmonary hypertension and the following conditions: HIV risk factor, degree of immunosuppression, presence or absence of AIDS, and presence or absence of liver cirrhosis. A retrospective study involving a search of the published literature on primary pulmonary hypertension among HIV cases from 1987 to 1998, using the Medline and Aidsline databases was conducted. Patients for whom secondary causes of pulmonary hypertension could be excluded were selected, and the following information for each was recorded: age, gender, risk factors for HIV infection, HIV disease stage according to the Centers for Disease Control, previous opportunistic and neoplastic diseases, CD4+ cell count (cells/L), presence or absence of liver cirrhosis, pulmonary systolic artery pressure level, and lung pathology specimens. Information about the patient's survival time was also recorded. Seventy-six patients were judged to have primary pulmonary hypertension and were included in the study. While no correlation was found between pulmonary systolic artery pressure level and CD4+ cell counts, a statistically significant difference was found between HIV-positive patients with and without AIDS as determined by the Centers for Disease Control criteria with regard to the degree of pulmonary hypertension, expressed as pulmonary systolic artery pressure level (85.4 +/- 17 mm Hg vs 71.8 +/- 15 mm Hg, p < 0.013). Although a higher PAPS was present in HIV cirrhotic patients, a statistically significant difference was not found between degree of pulmonary hypertension and evidence of hepatic cirrhosis (85 +/- 21 mm Hg vs 73.1 +/- 15 mm Hg, p < 0.062). Patients with AIDS and primary pulmonary hypertension present a higher degree of pulmonary hypertension than non-AIDS patients. Pulmonary hypertension associated with HIV seems to be related to a cytokine-related stimulation and proliferation of endothelium. High levels of cytokines present in AIDS patients can favor pulmonary hypertension, but the role of a host response to HIV--determined by one or more HLA subtypes--is suspected to enhance high cytokine production levels.

摘要

相似文献

1
Primary pulmonary hypertension in HIV patients: a systematic review.
Angiology. 2001 Jan;52(1):31-41. doi: 10.1177/000331970105200105.
2
Interventions for the prevention and management of oropharyngeal candidiasis associated with HIV infection in adults and children.成人及儿童HIV感染相关口咽念珠菌病的预防与管理干预措施。
Cochrane Database Syst Rev. 2006 Jul 19(3):CD003940. doi: 10.1002/14651858.CD003940.pub2.
3
Aerobic exercise interventions for adults living with HIV/AIDS.针对感染艾滋病毒/艾滋病的成年人的有氧运动干预措施。
Cochrane Database Syst Rev. 2005 Apr 18(2):CD001796. doi: 10.1002/14651858.CD001796.pub2.
4
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
5
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
6
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
7
Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.阿德福韦酯与聚乙二醇化干扰素α-2a治疗慢性乙型肝炎:系统评价与经济学评估
Health Technol Assess. 2006 Aug;10(28):iii-iv, xi-xiv, 1-183. doi: 10.3310/hta10280.
8
Sertindole for schizophrenia.用于治疗精神分裂症的舍吲哚。
Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD001715. doi: 10.1002/14651858.CD001715.pub2.
9
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
10
Population-based interventions for reducing sexually transmitted infections, including HIV infection.基于人群的减少性传播感染(包括艾滋病毒感染)的干预措施。
Cochrane Database Syst Rev. 2004(2):CD001220. doi: 10.1002/14651858.CD001220.pub2.

引用本文的文献

1
[Cardiovascular compromise in the infection by the human immunodeficiency virus].[人类免疫缺陷病毒感染中的心血管损害]
Arch Peru Cardiol Cir Cardiovasc. 2023 Mar 31;4(1):21-29. doi: 10.47487/apcyccv.v4i1.269. eCollection 2023 Jan-Mar.
2
gp120 Envelope Glycoproteins of HIV-1 Group M Subtype A and Subtype B Differentially Affect Gene Expression in Human Vascular Endothelial Cells.HIV-1 组 M 亚型 A 和 B 的 gp120 包膜糖蛋白差异影响人血管内皮细胞的基因表达。
Int J Mol Sci. 2023 Feb 10;24(4):3536. doi: 10.3390/ijms24043536.
3
Hypertension and human immunodeficiency virus: A paradigm for epithelial sodium channels?
高血压与人类免疫缺陷病毒:上皮钠通道的一个范例?
Front Cardiovasc Med. 2022 Aug 25;9:968184. doi: 10.3389/fcvm.2022.968184. eCollection 2022.
4
Viral Infection and Cardiovascular Disease: Implications for the Molecular Basis of COVID-19 Pathogenesis.病毒感染与心血管疾病:对 COVID-19 发病机制分子基础的影响。
Int J Mol Sci. 2021 Feb 7;22(4):1659. doi: 10.3390/ijms22041659.
5
COVID-19 patients may become predisposed to pulmonary arterial hypertension.COVID-19 患者可能易患肺动脉高压。
Med Hypotheses. 2021 Feb;147:110483. doi: 10.1016/j.mehy.2021.110483. Epub 2021 Jan 6.
6
Association of COVID-19 and other viral infections with interstitial lung diseases, pulmonary fibrosis, and pulmonary hypertension: A narrative review.2019冠状病毒病及其他病毒感染与间质性肺疾病、肺纤维化和肺动脉高压的关联:一项叙述性综述
Can J Respir Ther. 2020 Nov 26;56:1-9. doi: 10.29390/cjrt-2020-021. eCollection 2020.
7
Evaluation of dyspnea of unknown etiology in HIV patients with cardiopulmonary exercise testing and cardiovascular magnetic resonance imaging.心肺运动试验和心血管磁共振成像评估 HIV 患者不明原因呼吸困难。
J Cardiovasc Magn Reson. 2020 Oct 12;22(1):74. doi: 10.1186/s12968-020-00664-6.
8
Characteristics, Prevention, and Management of Cardiovascular Disease in People Living With HIV: A Scientific Statement From the American Heart Association.HIV 感染者的心血管疾病特征、预防和管理:美国心脏协会的科学声明。
Circulation. 2019 Jul 9;140(2):e98-e124. doi: 10.1161/CIR.0000000000000695. Epub 2019 Jun 3.
9
Drug abuse and HIV-related pulmonary hypertension: double hit injury.药物滥用与 HIV 相关肺动脉高压:双重打击损伤。
AIDS. 2018 Nov 28;32(18):2651-2667. doi: 10.1097/QAD.0000000000002030.
10
Design of the exercise MRI evaluation of HIV-pulmonary arterial hypertension longitudinal determinants (EXALTED) trial.EXALTED 试验:运动 MRI 评估 HIV 肺动脉高压纵向决定因素的设计。
J Cardiovasc Med (Hagerstown). 2017 Nov;18(11):888-896. doi: 10.2459/JCM.0000000000000575.